Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ZenaTech Signs Offer to Acquire a Flight School Enabling Complex BVLOS Missions and Potential Drone as a Service (DaaS) US Government and Military Contracts
-
Easy Environmental Solutions Secures Full Down Payment for First EasyFEN™ Units in Africa
-
Clene Reports Second Quarter 2025 Financial Results and Recent Operating Highlights
-
SoFi Announces Monthly Distributions on $THTA (12.00%)
-
Reborn Coffee Signs $1 Million Licensing Agreement to Expand into South Korea
-
scPharmaceuticals Receives Notice of Allowances of Multiple US Patent Applications Covering SCP-111
-
SecureTech Engages Craft Capital Management to Accelerate Capital Formation, National Exchange Uplisting, and Strategic M&A Growth
-
America’s Car-Mart, Inc. Regains Compliance With Nasdaq Filing Requirements
-
ECGI's Uplist Ventures Invests in Multilingual AI Sales and Marketing Platform AuraChat
-
Respected VMS Expert, Economic Geologist Dr. Stephen Piercey Joins Callinex’s Technical Team
-
Bath & Body Works to Report Second Quarter Results on August 28, 2025
-
Adial Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Fifty 1 Labs, Inc. and The Gates Foundation Lead Largest-Ever Sickle Cell Disease Study, Unlocking Pathways for Gene-Based and Repurposed Therapies
-
SecureTech Engages Craft Capital Management to Accelerate Capital Formation, National Exchange Uplisting, and Strategic M&A Growth
-
AI Multi-Agent System Transforms Communications Coaching
-
Enlivex to Present 3-Month Topline Data from Phase IIa Moderate/Severe Knee Osteoarthritis Trial on August 18 Webinar
-
America’s Patriotic Beer – American Rebel Light – Takes Center Stage at NHRA Brainerd International Raceway’s Biggest Fan Party in The Zoo with ‘Battle for the Rebel Axe” and CEO Andy Ross
-
Investigational Device Exemption (IDE) Application for Human Clinical Trials at Mayo Declined By FDA
-
Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy
-
DTST Reports 2025 Second Quarter Financial Results and Provides Business Update
-
MDWerks Issues Mid-Year Shareholder Update
-
Autonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing Catheter in Key Step Toward U.S. Clinical Studies
-
Amaze Reports Second Quarter 2025 Financial Results with 1,134% Year-Over-Year Revenue Growth
-
Fluent, Inc. Adds Authentic Brands Group to Partner Network, Powering Post-Purchase Monetization Across Brand Portfolio
-
ECD Automotive Strengthens Balance Sheet Through $10 Million Debt-for-Equity Exchange and Completes a $999,900 Equity Raise
-
Vivid Seats Unveils 2025 NFL Fan Loyalty Report
-
Salarius Pharmaceuticals Announces 1-for-15 Reverse Stock Split
-
Toppoint Holdings Inc. Reports Second Quarter 2025 Results; Import and Metal Expands
-
Surfshark celebrates three years as Heart of Midlothian FC’s official VPN partner
-
TechTAC Secures Patent for Slimline QuickSet Tubing Anchor Catcher
-
United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Home Use
-
ShowSeeker Named “Best Overall SalesTech Company” in 2025 MarTech Breakthrough Awards Program
-
Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights
-
Biotricity Reinforces Growth Trajectory, Kicking Off Fiscal 2026 with Strong First Quarter Results Featuring Revenue Growth, Positive EBITDA and Improved Margins
-
Polyrizon Regains Compliance with Nasdaq Listing Requirements
-
Maris-Tech to Showcase AI-Powered Video Intelligence and Edge Computing Solutions at DSEI 2025
-
Abell Pest Control Marks World Honey Bee Day with New Support for Canadian Bee Gut Research at University of Guelph
-
VivoSim Labs Appoints Tony Lialin as Chief Commercial Officer
-
24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with Multiple Phase 1B/2 Trial Readouts Expected in 2H 2025
-
Candel Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
-
Outlook Therapeutics Reports Financial Results for Third Quarter Fiscal Year 2025 and Provides Corporate Update
-
Entrée Resources Announces Second Quarter 2025 Results
-
Uphold Customers Can Now Add Funds to Wallets Instantly Using PayPal
-
Vortex Energy Successfully Deploys ANT Sensors at Robinsons River Salt Project
-
Virtual Gurus Announces Leadership Update as Founder Bobbie Racette Steps Down as CEO and Moves into Role of Founder & President
-
Sow Good Reports Second Quarter 2025 Results
-
CoreCivic Announces New Contract Award To Resume Operations At West Tennessee Detention Facility
-
Duos Edge AI and FiberLight Expand Strategic Partnership
-
Cerence Audio AI Integrates with HARMAN AudioworX to Enhance In-Car Experiences
-
Halda Therapeutics Receives FDA Fast Track Designation for HLD-0915 for the Treatment of Metastatic Castration-Resistant Prostate Cancer
